Acute Care Quality in Chronic Kidney Disease

  • Research type

    Research Study

  • Full title

    Acute Care QUAliTy in chronic Kidney Disease (The ACQUATICK Study)

  • IRAS ID

    132822

  • Contact name

    Charles Ferro

  • Contact email

    charles.ferro@uhb.nhs.uk

  • Sponsor organisation

    Head of Research and Development Governance Queen Elizabeth Hospital Birmingham

  • Research summary

    Chronic kidney disease (CKD) affects almost 1 in 7 of the population and confers a high risk of death to a large extent explained by an increased risk of cardiovascular disease. Increasing numbers of studies from North America have found that patients with CKD are less likely to be treated with measures to prevent cardiovascular disease, are less likely to receive treatments for a cardiovascular event when admitted to hospital and are less likely to be discharged with treatments aimed to prevent a further cardiovascular event. Chronic Kidney Disease is more common in the aged, more common in persons from Black, Asian and Minority Ethnic descent and in persons with lower socio-economic status. The influences these factors have on patient outcomes or on the treatments they receive are not known. \n\nThe Quality and Outcomes Framework is a system for the performance management and payment of general practitioners in the NHS. The clinical areas now include coronary heart disease, heart failure, stroke and transient ischaemic attacks, hypertension, diabetes mellitus and chronic kidney disease. The Hospital Episode Statistics (HES) database is an administrative dataset that collates information on all patients admitted to all NHS hospitals in England. Each admission contains a primary diagnosis and up to 19 secondary diagnoses, and up to 24 procedure fields. The Office of National Statistics (ONS) records all deaths in England. \n\nAdult patients admitted to hospital over a 2-year period will be consented to this study. Data will be extracted from their GP database and linked to HES and ONS. Linking primary care data with HES and ONS will allow, for the first time, healthcare researchers to examine a joined-up journey of patient care from primary and secondary care providing unequalled levels of information on treatment and outcomes of patients with CKD.

  • REC name

    West Midlands - South Birmingham Research Ethics Committee

  • REC reference

    13/WM/0317

  • Date of REC Opinion

    16 Sep 2013

  • REC opinion

    Further Information Favourable Opinion